The MEMORY biobank focuses on research into biomarkers for memory impairment and dementia and their validation in clinical cohorts. The population consists of patients with dementia syndrome, mild cognitive impairment (MCI) or subjective cognitive impairment (SCD). The biobank contains clinical data and biomaterial (DNA, serum and EDTA plasma).
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Control over Human Biomaterials Act [Wet zeggenschap lichaamsmateriaal] (Wzl)19 July 2022
The Ministry of Health, Welfare and Sport (VWS) is currently preparing a Control over Human Biomaterials Act [Wet zeggenschap lichaamsmateriaal] (Wzl) which will serve in the future as a specific legal framework for the (further) use of body tissue for medical scientific research.read more